Perelman School of Medicine

Two doctors in the Perelman School of Medicine at the University of Pennsylvania have been awarded Immuno-Oncology Innovative Research Grants (IRG) by Stand Up to Cancer (SU2C). Michael Farwell, MD, an assistant professor of Radiology, and Gregory L. Beatty, MD, PhD, an assistant professor of Hematology Oncology, and are two of just 10 researchers to receive these grants.

A new analysis of patients who have undergone treatment for prostate cancer shows a connection between androgen deprivation therapy (ADT) – a testosterone-lowering therapy and a common treatment for the disease – and dementia, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.

For a trove of examples of the rich outcomes of interdisciplinary work, look no further than Darko Stefanovski’s research portfolio.

From using fluid in the lungs to better understand the potential of immunotherapy treatments in lung cancer, to tracking circulating tumor cells in prostate cancer, to conducting RNA sequencing of cancer cell clusters from the blood of pancreatic cancer patients, to finding new ways to biopsy tissue from patients who may have esophageal cancer, a series of studies from the Perelman School

Humans dislike uncertainty. So what happens when that ambiguity comes from designated “experts” and relates to the genetic health of an unborn child?

Risa Lavizzo-Mourey has been named the University of Pennsylvania’s 19th Penn Integrates Knowledge University Professor, effective Jan. 1, 2018.  

Teenagers who self-report feeling drowsy mid-afternoon also tend to exhibit more anti-social behavior such as lying, cheating, stealing and fighting.

If you’ve ever wondered how a vaccine given decades ago can still protect against infection, you have your plasma cells to thank. Plasma cells are long-lived B cells that reside in the bone marrow and churn out antibodies against previously encountered vaccines or pathogens.